A randomised, controlled Phase 1/2 study in healthy adults to evaluate the safety and immunogenicity of an inulin-adjuvanted antigen-sparing seasonal trivalent inactivated influenza vaccine

Trial Profile

A randomised, controlled Phase 1/2 study in healthy adults to evaluate the safety and immunogenicity of an inulin-adjuvanted antigen-sparing seasonal trivalent inactivated influenza vaccine

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Adjuvants
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Vaxine
  • Most Recent Events

    • 29 Aug 2011 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
    • 13 May 2009 Status changed from not stated to not yet recruiting.
    • 13 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top